Abstract
GLORIOSA SUPERBA L.: A DIMINISHING WONDER

Pallavi Sharma and Tulika Mishra*

ABSTRACT

Gloriosa superba (Flame lily) is a creeper plant belonging to the family Colchicaceae. This plant has been used asa remedy in classical times. In rustic regions of Asian continents, the plant has been used as ethnomedicine. It has antimicrobial, antioxidant, anti-inflammatory, anthelmintic, and anti-coagulant properties. This plant is a rich source of important phytochemicals like colchicines and colchicocides, which are very expensive, as these are used in modern medicine, this plant is also exported from India. Colchicine has the potential for treating fatal diseases like cancer and it is also used to treat the hyper-inflammatory phase in COVID-19 patients. It is also used in prevention of cardiac diseases like pericarditis. In recent years, G. superba is copiously used as a source of colchicine to treat gout because colchicine is a substitute for those who are unable to tolerate non-steroidal anti-inflammatory drugs used in gout. Literature data revealed that this species is also used to cure disorders like rheumatism, arthritis, cholera, impotence, typhus, etc. This species is on the border of extinction and is included in the „Red Data Book' by the International Union for Conservation of Nature. Current communication tried to cover an overall review of various medicinal and pharmacological aspects of G. superba.

Keywords: .


[Full Text Article]   [Download Certificate]

Indexing

Best Article Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.

Best Article of current issue :

Dr. Dhrubo Jyoti Sen

Download Article : Click here

News & Updation

  • EJBPS: MARCH ISSUE PUBLISHED

    MARCH 2026 Issue has been successfully launched on 1 MARCH 2026.

  • EJBPS: New Impact Factor 2026

    EJBPS Impact Factor has been Increased from  7.482 to 8.181 for Year 2026.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.

     

Google Scholar Index Copernicus Indian Science Publications Urlich's Periodicals Directory, Proquest, UK (In Process) Research Bible, Fuchu, Tokyo. JAPAN UDLedge Science Citation Index International Society for Research activity (ISRA) Scientific Indexing Services (SIS) InfoBase Index (In Process) SJIF Impact Factor Scholar Article Impact Factor, SAIF Universal Impact Factor CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Global Impact Factor (GIF) (0.377) IP Indexing (IP Value 3.77) Web of Science Group (Under Process) Directory of Research Journals Indexing Scope Database Academia Academia Doi-Digital Online Identifier Doi-Digital Online Identifier ISSN National Centre Zenodo Indexing International CODEN Service, USA

UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS

Downloads

Copyright From

Covering Letter

                        Author Instruction 
 

PLAGERLUM REPORT